Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Mezzanine Equity and Shareholders??? Equity (Unaudited)

v3.24.3
Consolidated Statements of Mezzanine Equity and Shareholders’ Equity (Unaudited) - USD ($)
$ in Thousands
Redeemable Convertible Preferred Stock
Warrants To Placement Agent
Common Stock
Non-voting Common Stock
Additional paid-in capital
Accumulated deficit
Total
Balance at Dec. 31, 2022 $ 1 $ 36,666 $ (33,402) $ 3,265
Balance (in Shares) at Dec. 31, 2022     1,737,986      
Share based compensation 298 298
Share based compensation (in Shares)            
Repurchase of common stock [1] (50) (50)
Repurchase of common stock (in Shares)     (7,920)      
Issuance of common stock and pre-funded warrants upon private placement, net of underwriting commissions and other offering costs 104 [1] 1,356 1,356
Issuance of common stock and pre-funded warrants upon private placement, net of underwriting commissions and other offering costs (in Shares)     190,000        
Exercise of options into common stock [1] 10 10
Exercise of options into common stock (in Shares)     19,443        
Exercise of pre-funded warrants into common stock
Exercise of pre-funded warrants into common stock (in Shares)     754,670        
Reclassification of warrants from liabilities to equity 314 314
Net comprehensive loss for the period (4,355) (4,355)
Net comprehensive loss for the period (in Shares)            
Balance at Sep. 30, 2023 104 $ 1 38,594 (37,757) 838
Balance (in Shares) at Sep. 30, 2023     2,694,179      
Balance at Jun. 30, 2023 104 $ 1 38,174 (36,890) 1,285
Balance (in Shares) at Jun. 30, 2023     1,930,718      
Share based compensation 106 106
Exercise of options into common stock [1] [1] [1]
Exercise of options into common stock (in Shares)     8,791        
Exercise of Pre funded warrants into common stock (Note 7b) [1] [1]
Exercise of Pre funded warrants into common stock (Note 7b) (in Shares)     754,670        
Reclassification of warrants from liabilities to equity 314 314
Net comprehensive loss for the period (867) (867)
Balance at Sep. 30, 2023 104 $ 1 38,594 (37,757) 838
Balance (in Shares) at Sep. 30, 2023     2,694,179      
Balance at Dec. 31, 2023 159 $ 1 39,916 (39,688) $ 229
Balance (in Shares) at Dec. 31, 2023     3,007,745     3,007,745
Exercise of pre-funded warrants into common stock (in Shares)             970,187
Balance at Jun. 30, 2024 201 $ 1 42,687 (41,752) $ 936
Balance (in Shares) at Jun. 30, 2024     5,017,322      
Balance at Dec. 31, 2023 159 $ 1 39,916 (39,688) $ 229
Balance (in Shares) at Dec. 31, 2023     3,007,745     3,007,745
Share based compensation     259   $ 259
Vesting of RSUs
Vesting of RSUs (in Shares)     28,228 [1]      
Issuance of common stock, net of offering costs (note 7f)   [1] 316 316
Issuance of common stock, net of offering costs (note 7f) (in Shares)     227,939        
Exercise of options into common stock   [1] 32 $ 32
Exercise of options into common stock (in Shares)     21,225       21,225
Warrant to lender   61 $ 61
Exercise of Pre funded warrants into common stock (Note 7b)   [1]  
Exercise of Pre funded warrants into common stock (Note 7b) (in Shares) [1]     970,187        
Warrant inducement agreement, net of offering costs (Note 7e)   27 1,951 1,951
Warrant inducement agreement, net of offering costs (Note 7e) (in Shares) [1]     999,670        
Warrant inducement agreement, net of offering costs (Note 7d)   42 [1] 2,560 2,560
Warrant inducement agreement, net of offering costs (Note 7d) (in Shares)     999,670        
Net comprehensive loss for the period     (2,575) (2,575)
Balance at Sep. 30, 2024 228 $ 1 45,095 (42,263) $ 2,833
Balance (in Shares) at Sep. 30, 2024     6,254,664     6,254,664
Balance at Jun. 30, 2024 201 $ 1 42,687 (41,752) $ 936
Balance (in Shares) at Jun. 30, 2024     5,017,322      
Share based compensation         80   80
Vesting of RSUs    
Vesting of RSUs (in Shares) [1]     9,733        
Issuance of common stock, net of offering costs (note 7f)   [1]   316   316
Issuance of common stock, net of offering costs (note 7f) (in Shares)     227,939        
Warrant to lender     61   61
Warrant inducement agreement, net of offering costs (Note 7e)   27   1,951   1,951
Warrant inducement agreement, net of offering costs (Note 7e) (in Shares) [1]     999,670        
Net comprehensive loss for the period         (511) (511)
Balance at Sep. 30, 2024 $ 228 $ 1 $ 45,095 $ (42,263) $ 2,833
Balance (in Shares) at Sep. 30, 2024     6,254,664     6,254,664
[1] Represents an amount less than $1 thousand.